Jonathan Cebon is the Medical Director of the Cancer Services Unit at the Olivia Newton-John Cancer Wellness & Research Centre at Austin Health in Heidelberg and Medical Director of the Olivia Newton-John Cancer Research Institute. His clinical area of interest is the immune therapy of cancer.
He is a Professor in Medicine at the University of Melbourne and Fellow of the Royal Australasian College of Physicians. He is a lead investigator in the Victorian Cancer Agency funded Melbourne Melanoma Project. He serves on the Cancer Council of Victoria and has served as a member of the Consultative Council of the Victorian Cancer Agency. He serves on the Scientific Committee of the Cancer Vaccine Collaborative (CVC), an organisation that plays a major international role supporting basic, translational and clinical research into the immune therapy of cancer.
As a lead investigator for Ludgwig Institute for Cancer Research (LICR) and CVC in Australia for 20 years he has led more than 20 immunotherapy Phase I and II clinical trials and translational projects with immunotherapeutics.
Abstracts this author is presenting: